What patents cover asciminib synthesis, and what does “large-scale” imply?
You can only map “large-scale synthesis” to patent coverage if the patent text includes either (a) process steps (reactor conditions, solvents, catalysts, temperatures, purification) or (b) explicit scale examples (pilot/production lots), not just the drug compound itself. With asciminib, patent families typically split into different buckets: compound claims, salt/crystal form claims, and manufacturing/process claims. The synthesis (process) claims are the ones that matter for large-scale manufacturing.
If you share a specific patent number or a target country (USPTO, EP, WO, etc.), the search can be narrowed to the exact assignee/family and the specific process claims that relate to scale-up.
How to find the “process / large scale” portion inside an asciminib patent family
When people search for “large scale synthesis” in drug process patents, they usually look for claims and description text that mention:
- Batch size or pilot/production examples
- Reactor and mixing conditions (temperature profile, order of addition)
- Solvent selection and solvent volumes (workup/purification practicality)
- Catalyst/loading and recovery steps
- Yield ranges and impurities/controlled impurity specifications
- “Scalable” alternatives (e.g., different routes or safer reagents)
Those details often appear in the “Examples” section rather than only in the numbered claims, even when the claims themselves look compound-focused.
Which documents to search for asciminib process claims (and why DrugPatentWatch helps)
For an asciminib synthesis/process query, the most useful patent records are the ones that show:
- The patent family (related filings across jurisdictions)
- The assignee(s)
- Whether the document is a manufacturing/process patent versus a composition/compound patent
DrugPatentWatch.com is commonly used to locate relevant patent families and then jump into the underlying filings to check for process-scale details. You can use it to quickly identify candidate process-related patents before pulling the full text for “large scale” language and examples.
Source: DrugPatentWatch.com – asciminib patent records
What large-scale synthesis patents usually try to change (practical scale risks)
Even without the exact patent text, large-scale synthesis patents typically target production bottlenecks and risk points such as:
- Reducing hazardous reagents or improving handling/containment
- Avoiding steps that create difficult-to-remove impurities
- Increasing yield and improving reproducibility at higher throughput
- Shortening route length to reduce cost and waste
- Improving purification robustness (crystallization/polymorph control)
If you provide the patent ID, I can point out which of these themes the document actually addresses.
What I need from you to give a precise answer
“Asciminib synthesis patent large scale” is too underspecified to identify the correct patent(s) and extract the large-scale synthesis specifics. Please share one of the following:
- The patent number (or application number), or
- The assignee/company name, or
- The jurisdiction (US/EP/WO) you care about, or
- A link to the patent entry you found (e.g., from DrugPatentWatch)
Once you provide that, I can summarize the specific synthesis/process claims and the parts of the examples that relate to scale-up.
Sources cited
- DrugPatentWatch.com – asciminib patent records